ESC Premium Access

Long-term outcomes of Japan-specific dosage of rivaroxaban in high-risk patients with non-valvular atrial fibrillation: analysis from the XAPASS

Presentation

About the speaker

Professor Takanori Ikeda

Toho University, Tokyo (Japan)
1 presentation
0 follower

172 more presentations in this session

Atrial fibrillation with or without structural abnormalities. Analysis from a nationwide database.

Speaker: Doctor V. Mertz (FR)

Thumbnail

Epicardial adipose tissue and atrial fibrillation: guilty as charged or guilty by association?

Speaker: Doctor J. Sousa (Funchal, PT)

Thumbnail

Timing and degree of left atrial stunning and reverse functional remodeling following electrical cardioversion in patients with recent onset atrial fibrillation

Speaker: Doctor P. Arvanitis (Uppsala, SE)

Thumbnail

Irregular beat-to-beat hemodynamic properties determine left ventricular function during atrial fibrillation

Speaker: Doctor A. Lyon (Maastricht, NL)

Thumbnail

Genetic susceptibility, elevated blood pressure and risk of atrial fibrillation

Speaker: Mr M. Nazarzadeh (Oxford, GB)

Thumbnail

Access the full session

Atrial Fibrillation ePosters

Speakers: Professor T. Ikeda, Doctor V. Mertz, Doctor J. Sousa, Doctor P. Arvanitis, Doctor A. Lyon...
Thumbnail

About the event

Image

ESC CONGRESS 2020 - The Digital Experience

28 August - 1 September 2020

Sessions Presentations

This platform is supported by

logo Novo Nordisk